NCT06046950View on ClinicalTrials.gov

TrEatment Targets in Rheumatoid Arthritis: TETRA-study

NAActive, not recruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Treatment target DAS28CRP-LDA

Aiming for DAS28CRP-low disease activity

OTHER

Treatment target SDAI-remission

Aiming for SDAI-remission

Trial Locations (1)

6574 NA

Sint Maartenskliniek, Ubbergen

All Listed Sponsors
lead

Sint Maartenskliniek

OTHER

NCT06046950 - TrEatment Targets in Rheumatoid Arthritis: TETRA-study | Biotech Hunter | Biotech Hunter